Zusammenfassung
Wir berichten über den ersten uns bekannten Fall eines serologisch gesicherten Burkitt-Lymphoms in Deutschland. Die Histologie ergab das typische Bild eines „Sternenhimmels“. Das Serum des Patienten enthielt präcipitierende Antikörper gegen das aus Burkitt-Gewebe-Kulturzellen gewonnene Antigen. Der Antikörpertiter im indirekten Fluorescenztest war 1:640. Stoffwechseluntersuchung der Zellen ergab eine signifikante Glutaminmangelempfindlichkeit ohne gleichzeitige Asparaginabhängigkeit. Die klinischen Befunde, das typische histologische Bild und das initial eindrucksvolle Ansprechen auf die Chemotherapie zusammen mit dem hohen Antikörpertiter gegen das Epstein-Barr-Virus lassen die Diagnose Burkitt-Lymphom gesichert erscheinen. Epidemiologie, Klinik, Histologie und Immunologie werden im Lichte der heute bekannten Tatsachen über das Burkitt-Lymphom diskutiert.
Summary
We here report the first case of Burkitt-Lymphoma in Germany with positive serology. The serum of the patient showed precipitating antibodies against antigens derived from Burkitt cells, the antibody titer in the indirect fluorescence test with Burkitt tissue culture cells was 1:640. The cells showed a marked inhibition of protein synthesis in the absence of glutamine in the tissue culture medium. There was no inhibition in the absence of asparagine. The clinical features, the typical histology, the initially good response to chemotherapy, and the high anti-EBV antibody titer were consistent with the diagnosis Burkitt-Lymphoma. These findings are discussed, the current literature is reviewed.
Literatur
Ahlström, C. G., Andersson, T., Klein, G., Akermann, M.: Malignant lymphoma of Burkitt-typ in Sweden. Int. J. Cancer2, 583 (1967).
Armstrong, D., Henle, G., Henle, W.: Complement-fixation tests with cell lines derived from Burkitt's lymphomas and acute leukemias. J. Bact.91, 1257 (1966).
Broome, J. D.: Evidence, that L-asparaginase of guinea pig serum is responsible for its antilymphoma effect. J. exp. Med.118, 121 (1963).
Braband, H.: Burkitt-Tumor. Stuttgart: Georg Thieme 1968.
Burchenal, J. H., Burkitt, D. P. (editors): Treatment of Burkitt-tumor. UICC Monograph Ser., vol. 8, New York: Springer Berlin, Heidelberg 1967.
Burkitt, D., O'Conor, G. T.: Malignant lymphoma in African children. A clinical syndrome. Cancer, (Philad.)14, 258 (1961).
—— Davies, J. N. P.: Lymphoma syndrome in Uganda and tropical Africa Med. Press245, 367 (1961).
—— Sarcoma involving jaws in African children Brit. J. Surg.46, 218 (1959).
Burkitt, D. P.: Etiology of Burkitt's lymphoma an alternative hypothesis to a vectored virus. J. nat. Cancer Inst.42, 19 (1969).
Camain, R., Lambert, D.: Les hématosarcomes de la face chez l'enfant en Afrique. (Maladie de Burkitt) Rev. franc. Etud. klin. biol.10, 587 (1968).
Campbell, H. A., Mashburn, L. T., Boyse, E. A., Old, L. J.: Two L-asparaginases from E. Coli B, their separation, purification and antitumor-activity. Biochemistry6, 721 (1967).
Chapman, D. S., Jenkins, T.: The Burkitt-lymphoma in natal. Med. Proc.9, 320 (1963).
Dalldorf, G., Linsell, C. A., Barnhart, F. E., Martyn, R.: An epidemiological approach to the lymphomas of African children and Burkitt sarcoma of the jaws. Perspect. Biol. Med.7, 435 (1964).
Diamandopoulis, G. T., Smith, E. B.: Phagocytosis in reticulum cell sarcoma. Cancer (Philad.)17, 329 (1964).
Diehl, V., Henle, G., Henle, E., Kohn, G.: Demonstration of herpes group virus in cultures of peripheral leucocytes from patients with infectious mononucleosis. Virology2, 663 (1968).
Dorfmann, R. F.: Diagnosis of Burkitts tumor in the United States. Cancer (Philad.)21, 563 (1968).
Eagle, H., Oyame, V. I., Levy, M., Horton, C. L., Fleischmann, R.: The growth response of mammalian cells in tissue culture ot L-glutamine and L-glutamic acid. J. biol. Chem.218, 607 (1956).
—— Amino-acid-metabolism in mammalian cell cultures. Science130, 432 (1959).
—— The specific amino acid requirements of a human carcinoma cell (Strain Hela) in tissue culture. J. exp. Med.102, 37 (1955).
El Asmar, F. A., Greenberg, D. M.: Studies on the mechanism of inhibition of tumor growth by the enzyme glutaminase. Cancer Res.26, 116 (1966).
Epstein, M. A., Achong, B. G.: Immunologic relationship of the herpes-like EB-virus of cultured Burkitt-lymphoblasts. Cancer Res.27, 2489 (1967).
—— Barr, Y., Achong, B. G.: Studies with Burkitt-lymphoma Wistar Inst. Symposium Monograph4, 69 (1965).
Evans, A. S., Niederman, J. C., McCollum, R. W.: Seroepidemiologic studies of infectious mononucleosis with EB virus. New Engl. J. Med.279, 1121 (1968).
Fink, M. A., King, G. S., Mizell, M.: Identity of a herpes virus antigen from Burkitt lymphoma of man and the Lukké adenocarcinoma of frogs. Nat. Cancer Inst.41, 1477 (1968).
Gerber, P., Birch, M.: Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc. nat. Acad. Sci. (Wash.)58, 478 (1967).
—— Hamre, D., Moy, A., Rosenblum, E. N.: Infectious mononucleosis, complement-fixing antibodies to herpes-like-virus associated with Burkitt lymphoma. Science161, 173 (1968).
Greenberg, D. M., Blumenthal, G., Ramadan, M. E. A.: Effect of administration of enzyme glutaminase on the growth of cancer cells. Cancer Res.24, 957 (1964).
Griffin, E. R., Wright, D. H., Bell, T. M., Ross, M. G. R.: Demonstration of virus particles in biopsy material from cases of Burkitt-tumor. Europ. Cancer2, 353 (1966).
Haddow, A. J.: Age incidence in Burkitt's lymphoma syndrome. E. Afr. med. J.41, 1 (1964).
Hake, Th.: Unveröffentlicht.
Henle, W.: Evidence for viruses in acute leukemia and Burkitt's tumor. Cancer (Philad.)21, 580 (1968).
Henle, G., Henle, W., Diehl, V.: Relation of Burkitt's tumor-associated herpes type virus to infectious mononucleosis. Proc. nat. Acad. Sci. (Wash.)59, 94 (1968).
—— —— Immunofluorescence, interference and complement-fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines. Cancer Res.27, 2442 (1967).
Hummeler, K., Henle, G., Henle, W.: Fine structure of a virus in cultered lymphoblasts from Burkitt lymphoma. J. Bact.91, 1366 (1966).
Klein, G., Pearson, G., Nadkarni, I. S., Nadkarni, J. J., Klein, E. Henle, G., Henle, W, Clifford, P.: Dependance of cell membrane immunofluorescence on presence of EB virus. J. exp. Med.128, 1011 (1968).
——: Search for host defenses in Burkitt lymphoma: Membrane immunofluorescence tests in Biopsies and tissue culture lines. Cancer Res.27, 2510 (1967).
——, Stjernswärd, J.: Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc. Nat. Acad. Sci. (Wash.)55, 1628 (1966).
Lennert, K.: Zit. bei (4, S. 100).
O'Conor, G. T.: Significant aspects of childhood lymphoma in Africa. Cancer Res.23, 1514 (1963).
-- Rappaport, H., Smith, E. B.: Childhood lymphoma resembling Burkitt's tumor in the U.S. Cancer (Philad.)18, 411 (1965).
O'Conor, G. T.: Malignant lymphoma in African children, a pathologicla entity. Cancer (Philad.)14, 270 (1961).
—— Davies, J. N. P.: Malignant tumors in African children. J. Pediat.56, 526 (1960).
Oettgen, H. F., Old, L. J., Boyse, E. A., Cambell, H. A., Philips, F. S., Clarkson, B. D., Talal, L., Leeper, R. D., Schwartz, M. K., Kim, J. H.: Inhibition of leukemias in man by L-asparaginase. Cancer Res.27, 2619 (1967).
—— Burkitt, D., Burchenal, J. H.: Malignant lymphoma involving the jaw in African children: Treatment with methotrexate. Cancer16, 616 (1963).
—— Burchenal, J. H.: Malignant lymphoma involving the jaw in African children Cancer Chemother. Rep.27, 45 (1963).
—— Aoki, T., Geering, G., Boyse, E. A., Old, L. J.: Definition of an antigenic system associated with Burkitt-lymphoma. Caucer Res.27, 2532 (1967).
—— Burkitt, D.: Malignant lymphoma involving the jaw in African children. Treatment with alkylating agents and actinomycin D. Cancer Chemother. Rep.28, 25 (1963).
Old, L. J., Kirkwood, J.: Vortrag auf Kongress über Amphibian Tumor Viruses. Okt. 1968.
—— Boyse, E. A.: Immunology of experimental tumors Ann. Rev. Med.15, 167 (1964).
—— —— Oettgen, H. F., Harven, E. de, Geering, G., Williamson, B., Clifford, P.: Precipitating antibody in human serum to an antigen present in cultured Burkitt-lymphoma cells. Proc. nat. Acad. Sci. (Wash.)56, 1699 (1956).
Rabinovitz, M., Olson, M. E., Greenberg, D. M.: Role of glutamine in protein synthesis by the Ehrlich ascites carcinoma. J. biol. Chem.222, 879 (1956).
Rabson, A. S., O'Conor, G. T., Baron, S., Whang, J. J., Legallais, F. Y.: Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int. J. Cancer1, 89 (1966).
Rappaport, H., Wright, D. H., Dorfmann, R. R.: Suggestted criteria for the diagnosis of Burkitt's tumor. Cancer Res.27, 2632 (1967).
Schmidt, C. G., Gallmeier, W. M.: Zur Enzymtherapie der Leukämien Dtsch. med. Wschr.93, 2299 (1968).
Stewart, S., Lovelace, E., Whang, J., Ngu, V.: Burkitt tumor, tissue culture, cytogenetic and virus studies. J. nat. Cancer. Inst.34, 319 (1965).
Stück, B., Old, L. J., Boyse, E. A.: Antigenic conversion of established leukemias by an unrelated leukemogenic virus. Nature (Lond.)202, 1016 (1964).
Ten Seldam, R. E. J., Cooke, R., Atkinson, L.: Childhood lymphoma in the territories of Papua and New Guinea. Cancer (Philad.)19, 437 (1966).
Wright, D. H.: Burkitt's tumor in England, a comparison with childhood lymphosarcoma Int. J. Cancer1, 503 (1966).
—— The epidemiology of Burkitt's tumor. Cancer Res.27, 2424 (1967).
—— Burkitt's tumor and childhood lymphosarcoma. Clin. Pediat. (Philad.)6, 116 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gallmeier, W.M., Göbel, F.W., Hartung, W. et al. Studien an einem Burkitt-Lymphom. Klin Wochenschr 48, 537–542 (1970). https://doi.org/10.1007/BF01488568
Issue Date:
DOI: https://doi.org/10.1007/BF01488568